{"id":"W4416086835","doi":"10.1016/j.jid.2025.09.173","title":"158 APG777, a Novel, Half-Life Extended Anti-IL-13 Antibody, Demonstrates Safety and Efficacy in Moderate-to-Severe Atopic Dermatitis: 16-Week Results From the Phase 2 APEX Study","year":2025,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada); SKiN Health","funders":"","keywords":"Apex (geometry); Phase (matter); Safety profile; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006767,0.0007016226,0.001032856,0.0002225912,0.0002188315,0.0006314155,0.000647817,0.0008628679,0.003211494],"category_scores_gemma":[0.0003507175,0.0002301931,0.0008568093,0.0001853429,0.0005095464,0.000565842,0.0002185367,0.00218097,0.0009369705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003545866,"about_ca_system_score_gemma":0.0006484718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004423667,"about_ca_topic_score_gemma":0.001025838,"domain_scores_codex":[0.9997649,0.00007864946,0.0000139345,0.00003052831,0.00004946806,0.00006257238],"domain_scores_gemma":[0.9997278,0.00006218322,0.00004292736,0.00002881836,0.00003127577,0.0001070507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2249942,0.03743415,0.006977506,0.001470252,0.001338358,0.0009030074,0.0002604819,0.002495684,0.3384433,0.0005238206,0.007769062,0.3773902],"study_design_scores_gemma":[0.2043364,0.6780466,0.02877285,0.0001328384,0.0009695387,0.002064095,0.0001836055,0.002855368,0.06577972,0.0004564774,0.01631735,0.00008521186],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886645,0.005575789,0.001352453,0.0004476581,0.0001426644,0.0005053811,0.0008241133,0.0001619364,0.002325481],"genre_scores_gemma":[0.9881573,0.00347805,0.001832955,0.0008607171,0.0001331343,0.0003983413,0.001792019,0.00005618399,0.003291281],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003211494,"threshold_uncertainty_score":0.01074356,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02772429506793801,"score_gpt":0.322711179342569,"score_spread":0.294986884274631,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}